Gain therapeutics inc.

Major-Pharmaceuticals

GANX


Executive/
Director

Price

  • Last Close
  • $ 1.81
    $ +0.78 75.73 %
    Dec 9, 2024
  • 52-Week High/Low
  • $5.04 - $0.94
  • YTD
  • -44.6%

  • Trading Volume
  • 1,540
  • Market Cap Full
  • $ 23.4M
  • Shares Outstanding
  • 12.9M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -24.9% 54% 15.5%
Q2 - - - - - - -32.9% -11.8% -7.1% 1.6%
Q3 - - - - - - -25.6% -9.4% -27.9% -
Q4 - - - - - - -27.1% -4% -0.2% -
J F M A M J J A S O N D
2024 18.5% 16% -16% 3.2% - - - - - - - -
2023 26.5% 5.1% 15.9% 4.4% -8.4% -2.8% -11.4% -16.6% -2.4% -11.5% -25.2% 52.6%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-42%4%-45%

Earnings

2020 2021 2022 2023
Q1 - -0.5 -0.28 -0.43
Q2 - -0.3 -0.43 -0.62
Q3 - -0.39 -0.38 -0.37
Q4 - -0.18 -0.39 -
A -1.3 -1.4 -1.5 -1.42

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 11.9 11.9
Jun 11.9 11.9 12.3
Sep 11.9 11.9 12.7
Dec 11.9 11.9 12.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio 0.1 - 0.1 - -
Debt – Equity Ratio 0.1 - 0.2 - -
Interest Coverage - - -3 - -
Equity multiplier 0.1 - - - -